Early research (Phase 1)Study completedNCT04449276
What this trial is testing
Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19
Who this might be right for
Severe Acute Respiratory SyndromeCoronavirusSARS-CoV-2+1 more
CureVac 280